New York, Jan 4, 2026, 10:28 ET — Market closed
- CoreWeave shares ended Friday up 10.8% after an SEC filing detailed changes to a key credit facility.
- The AI cloud firm lowered near-term liquidity requirements and pushed out the start of certain lender tests.
- Insider filings showed executive share sales tied largely to tax withholding on vested stock awards.
CoreWeave shares surged in the last U.S. session after the company disclosed amendments to a delayed-draw term loan facility that eased near-term liquidity requirements and delayed some covenant testing, an SEC filing showed. Securities and Exchange Commission
The Nvidia-backed AI cloud provider’s stock closed Friday at $79.32, up $7.70, or 10.8%, after trading between $72.95 and $81.11. Volume topped 30 million shares.
The filing lands at a sensitive moment for highly leveraged “AI infrastructure” companies, which need steady hardware deliveries and customer ramp-ups to turn booked demand into cash while staying inside lender guardrails.
A covenant is a financial rule set by lenders. When companies ask to adjust covenants, equity investors often read it as a sign that timing mismatches — between spending on equipment and collecting from customers — matter as much as demand.
CoreWeave said its subsidiary and the parent entered into a “First Amendment” to the DDTL 3.0 credit agreement and a related guarantee and pledge agreement on Dec. 31. Securities and Exchange Commission
The amendment cut the “minimum liquidity amount” — cash and similar resources that must be maintained — to $100 million for monthly payment dates from March 1, 2026 through April 30, 2026, the filing said. Securities and Exchange Commission
It also postponed the first testing date for the debt service coverage ratio to Oct. 31, 2027. That ratio is a standard measure of whether cash generation can cover required debt payments. Securities and Exchange Commission
CoreWeave added flexibility to fix covenant breaches through “equity cures,” which allow a borrower to inject equity to remedy a missed test. It can use an unlimited number of such cures for certain covenants through Oct. 28, 2026, the filing said. Securities and Exchange Commission
In the filing signed by Chief Executive Michael Intrator, the company said the amendment “aligns the facility for the timing of deliveries” described on its most recent earnings call. Securities and Exchange Commission
Separate Form 4 disclosures showed insider transactions dated Dec. 31, including sales tied to tax withholding obligations connected to vested restricted stock units, filings showed. Securities and Exchange Commission
CoreWeave’s shares have been volatile since late 2025, when the company trimmed its annual revenue forecast after a delay at a third-party data center partner, Reuters reported at the time. Reuters
Still, covenant relief does not remove the bigger risk investors have flagged: the business remains capital intensive, and any fresh slippage in delivery schedules or customer timing can pressure liquidity even before formal covenant tests begin.
Next, investors will watch for CoreWeave’s annual report on Form 10-K for the year ended Dec. 31, 2025, where the company said it expects to file the full text of the amendment as an exhibit. Securities and Exchange Commission
